Clinical trial
The Incidence, Inheritance, and Prognostic Significance of Polymorphisms in the RASSF1A Gene in Children With Wilms Tumors
NCT00088803 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Incidence, Inheritance, and Prognostic Significance of Polymorphisms in the RASSF1A Gene in Children With Wilms Tumors
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- Not reported
- Enrollment
- 471 (estimated)
- Sites
- 232
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer